|Bid||203.87 x 1800|
|Ask||204.98 x 800|
|Day's range||201.49 - 204.95|
|52-week range||161.65 - 262.00|
|Beta (5Y monthly)||1.37|
|PE ratio (TTM)||22.18|
|Earnings date||20 Feb 2024 - 26 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||211.04|
Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Charles River's (CRL) share price is likely to grow, backed by the strength of the DSA segment.
Charles River (CRL) and GC4K announce a gene therapy manufacturing collaboration.